Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1051289

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will support the call by Kidney Cancer UK to fund research on a national screening programme for kidney cancer.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	214526
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.</p><p> </p><p>The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer, however, the Committee welcomes new topic proposals via its annual call for topics which opens each year from September - December.</p><p> </p><p>Ministers carefully consider all recommendations made by the UK NSC.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:47:54 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1051291

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incinerators: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) Public Health England (i) received and (ii) commissioned assessments of the effect on peoples' health of emissions from waste incinerators disposing of plastic.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	214451
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) has not received or commissioned any assessments on disposing of plastic waste by incineration.</p><p> </p><p>When consulted, PHE provides an expert and independent opinion to the regulator, the Environment Agency, on the potential impacts on human health of emissions arising from existing or proposed regulated facilities, such as municipal waste incinerators (MWIs). Emissions from existing regulated facilities are closely monitored and regulated by the Environment Agency.</p><p> </p><p>PHE’s position is that well run and regulated modern MWIs are not a significant risk to public health when incinerating the general municipal waste mix which includes plastic.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:45:22 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1051292

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 January 2019 to Question 206215 on Air Pollution, what the implications for his policies are of the statement in the Public Health England report, published in March 2017, entitled Air Quality A Briefing for Directors of Public Health that PM is inhaled into the lungs and ultrafine PM0.1 is thought to pass into the blood causing many adverse outcomes including systemic inflammation.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	214452
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) has developed a programme to support national and local government to reduce the burden of disease attributable to air pollution. This includes awareness raising, developing the evidence base on the health effects of air pollution and interventions aiming to reduce exposure to air pollution and provide wider public health benefits.</p><p> </p><p>PHE undertakes various air quality research projects, working with academic partners, to review the evidence for the health effects of air pollutants. PHE is a partner in two health protection research units (HPRU) funded by the National Institute for Health Research, whose remit includes air pollution research: The Health impact of Environmental Hazards HPRU and the HPRU in Environmental Change and Health. Further information can be found at the following links:</p><p> </p><p><a href="http://hieh.hpru.nihr.ac.uk/" target="_blank">http://hieh.hpru.nihr.ac.uk/</a></p><p> </p><p><a href="http://www.hpru-ech.nihr.ac.uk/" target="_blank">http://www.hpru-ech.nihr.ac.uk/</a></p><p> </p><p>None of the research projects specifically focus on PM0.1 but address air pollution components which are included in this category.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:17:23 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1051293

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Waste Disposal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 January 2019 to Question 212301 on Food Waste: Disposal, whether (a) his Department and (b) Public Health England undertook an assessment of the effect on (i) human health and (ii) air quality of the collection and recycling of food waste.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	214453
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) has not made a specific assessment of the potential effect on public health of the collection and recycling of food waste. However, PHE has been involved in reviewing the current evidence for the potential health effects of bioaerosols resulting from composting facilities, including facilities recycling food waste. This assessment concluded that while there is some suggestive, albeit limited, qualitative evidence linking bioaerosol emissions from composting facilities to possible respiratory effects, further study is needed for confirmation and to explore other health outcomes. The report is available to view at the following link:</p><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/25825807" target="_blank">https://www.ncbi.nlm.nih.gov/pubmed/25825807</a></p><p>The Department for Environment, Food and Rural Affairs’ Resources and Waste Strategy details the Government’s ambitions for minimising the environmental impacts of waste whilst maximising its value as a resource. The strategy is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/resources-and-waste-strategy-for-england" target="_blank">https://www.gov.uk/government/publications/resources-and-waste-strategy-for-england</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:46:55 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1051294

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incinerators: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether Public Health England assesses evidence submitted by applicants for planning permission of the projected or estimated effect of waste incinerators on (a) air quality and (b) human health of future emissions (i) PM0.1 (ii) PM1 and (iii) PM 2.5.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	214454
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Public Health England (PHE) is not a statutory consultee under the planning regime. Local authority planners should consider consulting the Director of Public Health on any planning applications (including at the pre-application stage) that are likely to have a significant impact on the health and wellbeing of the local population or particular groups within it. This guidance can be viewed at the following links:</p><p> </p><p><a href="https://www.gov.uk/guidance/consultation-and-pre-decision-matters#Statutory-consultees-on-applications" target="_blank">https://www.gov.uk/guidance/consultation-and-pre-decision-matters#Statutory-consultees-on-applications</a></p><p> </p><p><a href="https://www.gov.uk/guidance/health-and-wellbeing#health-organisation-contact" target="_blank">https://www.gov.uk/guidance/health-and-wellbeing#health-organisation-contact</a>.</p><p> </p><p>Where consulted on planning applications, PHE takes the view that emissions from such plants are best considered as part of the associated environmental permit application. PHE is consulted by the Environment Agency and provides an independent opinion on all bespoke environmental permit applications, such as municipal waste incinerators, with regard to public health impacts. These assessments cover a range of emissions to air, water and land, including but not exclusively particulate matter. The role of PHE can be viewed at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/477277/Environmental_permitting_guide_Nov_2015.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/477277/Environmental_permitting_guide_Nov_2015.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 13:43:15 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1051336

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Autoimmune Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the public purse of treating and managing (a) rheumatoid arthritis, (b) inflammatory bowel disease and (c) psoriasis.
tabling member constituency	St Ives
tabling member printed	Derek Thomas
uin	214623
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific estimate has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:23:09 answering member 4067 label Biography information for Steve Brine
tabling member	4532 label Biography information for Derek Thomas

1051338

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Autoimmune Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) NHS England have made a comparative assessment of the effectiveness of treating immune-mediated inflammatory conditions (i) holistically and (ii) according to the physical location of the inflammation; and if he will make a statement.
tabling member constituency	St Ives
tabling member printed	Derek Thomas
uin	214625
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific assessment has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:21:20 answering member 4067 label Biography information for Steve Brine
tabling member	4532 label Biography information for Derek Thomas

1051440

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	214517
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Guidance is available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p> </p><p>Information about the symptoms, causes, diagnosis, treatment and complications of Kawasaki disease is also available on the National Health Service website.</p><p> </p><p>Furthermore, learning information and resources for clinicians about Kawasaki disease is available from Societi, The UK Kawasaki Disease Foundation. Societi engages with a range of NHS stakeholders to raise awareness of Kawasaki disease, and has a number of senior clinicians on its Scientific Advisory Board who work in leading NHS institutions and who have expertise in relevant clinical areas such as vasculitis and paediatric cardiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:22:23 answering member 4067 label Biography information for Steve Brine
tabling member	1400 label Biography information for Kevin Brennan

1051473

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the delay to the proposed doubling of places on the PrEP Impact Trial on his Department's commitment to ending new HIV transmissions by 2030.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	214541
answer	answer is ministerial correction date of answer 04/02/2019 answer text <p>On 30 January, the Secretary of State for Health and Social Care announced that the Pre-exposure Prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this later in February. The Secretary of State also announced the Government’s commitment to ending new HIV transmissions in England by 2030. To support this work, an expert group will be established to develop an action plan over the course of this year. The important role of PrEP, as part of combination HIV prevention efforts, will be considered as part of this process.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 214542 214543 question first answered 04/02/2019 18:09:57 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

1051474

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to introduce the doubling of places on the PrEP Impact Trial.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	214542
answer	answer is ministerial correction date of answer 04/02/2019 answer text <p>On 30 January, the Secretary of State for Health and Social Care announced that the Pre-exposure Prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this later in February. The Secretary of State also announced the Government’s commitment to ending new HIV transmissions in England by 2030. To support this work, an expert group will be established to develop an action plan over the course of this year. The important role of PrEP, as part of combination HIV prevention efforts, will be considered as part of this process.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 214541 214543 question first answered 04/02/2019 18:09:57 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger